Compare CYCN & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYCN | ULY |
|---|---|---|
| Founded | 2018 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 4.0M |
| IPO Year | N/A | N/A |
| Metric | CYCN | ULY |
|---|---|---|
| Price | $1.42 | $2.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 49.3K | ★ 69.1K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,855,000.00 | ★ $127,932,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.95 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1371.65 | N/A |
| 52 Week Low | $1.28 | $1.74 |
| 52 Week High | $6.25 | $17.99 |
| Indicator | CYCN | ULY |
|---|---|---|
| Relative Strength Index (RSI) | 40.67 | 43.31 |
| Support Level | $1.43 | $1.85 |
| Resistance Level | $1.64 | $2.26 |
| Average True Range (ATR) | 0.12 | 0.31 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 14.63 | 22.46 |
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.